The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

per Benjamin, Jonathan E., Stein, Anthony S.
Publicat a Ther Adv Hematol (2016)

Driving Simulator Performance in Patients with Possible and Probable Alzheimer’s Disease

per Stein, Anthony C., Dubinsky, Richard M.
Publicat 2011

Venetoclax-containing regimens in acute myeloid leukemia

per Aldoss, Ibrahim, Pullarkat, Vinod, Stein, Anthony S.
Publicat a Ther Adv Hematol (2021)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy

per Khaldoyanidi, Sophia, Nagorsen, Dirk, Stein, Anthony, Ossenkoppele, Gerrit, Subklewe, Marion
Publicat a J Clin Oncol (2021)

Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors

per Stein, Anthony S., Schiller, Gary, Benjamin, Ramsis, Jia, Catherine, Zhang, Alicia, Zhu, Min, Zimmerman, Zachary, Topp, Max S.
Publicat a Ann Hematol (2018)

Improved Outcomes Using Tacrolimus/Sirolimus for Graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as...

per Snyder, David S., Palmer, Joycelynne, Gaal, Karl, Stein, Anthony S., Pullarkat, Vinod, Sahebi, Firoozeh, Vora, Nyana, Nakamura, Ryotaro, Forman, Stephen J.
Publicat 2009

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

per Rosenthal, Joseph, Wong, Jeffrey, Stein, Anthony, Qian, Dajun, Hitt, Debbie, Naeem, Hossameldin, Dagis, Andrew, Thomas, Sandra H., Forman, Stephen
Publicat 2011

Dose Escalation of Total Marrow Irradiation with Concurrent Chemotherapy in Patients with Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

per Wong, Jeffrey Y.C., Forman, Stephen, Somlo, George, Rosenthal, Joseph, Liu, An, Schultheiss, Timothy, Radany, Eric, Palmer, Joycelynne, Stein, Anthony
Publicat a Int J Radiat Oncol Biol Phys (2012)

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

per Sun, Weili, Liu, Huaying, Kim, Young, Karras, Nicole, Pawlowska, Anna, Toomey, Debbie, Kyono, Wade, Gaynon, Paul, Rosenthal, Joseph, Stein, Anthony
Publicat a J Hematol Oncol (2018)

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

per Cook, Amy M., Li, Liang, Ho, Yinwei, Lin, Allen, Li, Ling, Stein, Anthony, Forman, Stephen, Perrotti, Danilo, Jove, Richard, Bhatia, Ravi
Publicat 2014

Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

per Topp, Max S., Zimmerman, Zachary, Cannell, Paul, Dombret, Hervé, Maertens, Johan, Stein, Anthony, Franklin, Janet, Tran, Qui, Cong, Ze, Schuh, Andre C.
Publicat a Blood (2018)

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

per Stein, Anthony S., Larson, Richard A., Schuh, Andre C., Stevenson, William, Lech-Maranda, Ewa, Tran, Qui, Zimmerman, Zachary, Kormany, William, Topp, Max S.
Publicat a Blood Adv (2018)

Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis

per Topp, Max S., Stein, Anthony S., Gökbuget, Nicola, Horst, Heinz‐August, Boissel, Nicolas, Martinelli, Giovanni, Kantarjian, Hagop, Brüggemann, Monika, Chen, Yuqi, Zugmaier, Gerhard
Publicat a Cancer Med (2021)

Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

per Stein, Anthony, Franklin, Janet L., Chia, Victoria M., Arrindell, Deborah, Kormany, William, Wright, Jacqueline, Parson, Mandy, Amouzadeh, Hamid R., Choudhry, Jessica, Joseph, Guiandre
Publicat a Drug Saf (2018)

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia

per Aldoss, Ibrahim, Zhang, Jianying, Pillai, Raju, Shouse, Geoff, Sanchez, James F, Mei, Matthew, Nakamura, Ryotaro, Stein, Anthony S, Forman, Stephen J, Marcucci, Guido, Pullarkat, Vinod
Publicat a Br J Haematol (2019)

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia...

per Rambaldi, Alessandro, Ribera, Josep‐Maria, Kantarjian, Hagop M., Dombret, Hervé, Ottmann, Oliver G., Stein, Anthony S., Tuglus, Catherine A., Zhao, Xiaoyue, Kim, Christopher, Martinelli, Giovanni
Publicat a Cancer (2019)

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

per Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Stein, Anthony S., Dombret, Hervé, Chen, Yuqi, Ribera, Josep‐Maria, Bargou, Ralf C., Horst, Heinz‐August, Kantarjian, Hagop M.
Publicat a Cancer (2020)

Exosome-driven lipolysis and bone marrow niche remodeling support leukemia expansion

per Kumar, Bijender, Orellana, Marvin, Brooks, Jamison, Madabushi, Srideshikan Sargur, Vishwasrao, Paresh, Parra, Liliana E., Sanchez, James, Salhotra, Amandeep, Stein, Anthony, Chen, Ching-Cheng, Marcucci, Guido, Hui, Susanta Kumar
Publicat a Haematologica (2020)

Reduced intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia

per Stein, Anthony S., Palmer, Joycelynne M., O'Donnell, Margaret R., Kogut, Neil M., Spielberger, Ricardo T., Slovak, Marilyn L., Tsai, Ni-Chun, Senitzer, David, Snyder, David S., Thomas, Sandra H., J.Forman, Stephen
Publicat 2009

Targeting MCL-1 in Hematologic Malignancies: Rationale and Progress

per Wei, Andrew H., Roberts, Andrew W., Spencer, Andrew, Rosenberg, Aaron Seth, Siegel, David, Walter, Roland B., Caenepeel, Sean, Hughes, Paul, McIver, Zach, Mezzi, Khalid, Morrow, Phuong Khanh, Stein, Anthony
Publicat a Blood Rev (2020)